This is to inform that the Implementation Committee, in its meeting held today, viz. Friday, January 09, 2026, which commenced at 03:00 P.M. (IST) and concluded at 03:46 P.M. (IST) through ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare's Resolution Plan Implementation Committee met on January 9, 2026 and approved three major actions following the NCLT's approval of the company's resolution plan on December 18, 2025. First, it appointed an Interim Board of four directors — Mr. Pradeep Kumar Jain and Mr. Rajesh Jain as promoter non-executive directors, plus Mr. Manish Goswami and Mr. Anjani Misra as independent directors — whose powers remain suspended until the resolution plan closure. Second, it set January 16, 2026 as the record date to cancel existing equity shares held by the erstwhile promoters and current public shareholders. Third, it approved the issuance of 2.37 crore fresh equity shares at INR 10 each (totalling INR 23.75 crore) on a preferential basis to three new promoters — Ananta Medicare Limited (1.375 crore shares / 55%), Mr. Rajesh Jain (52.5 lakh / 21%), and Mr. Pradeep Kumar Jain (47.5 lakh / 19%) — who will together own 95% of the restructured company. Post-allotment, the total paid-up equity capital will stand at INR 25 crore (2.5 crore shares).
This marks the formal exit of Cian Healthcare from the insolvency process and a complete change of control — existing shareholders will have their shares extinguished, while the new promoter group (led by Ananta Medicare and the Jain family) will effectively run the reconstituted company. Retail investors holding CHCL shares as of record date should expect a total loss of their existing holdings and should watch for the final reconstitution details.